How Norstella is embedding artificial intelligence to improve pipeline to patient decision-making

Published on July 8, 2024

As drug discovery becomes more complex, expensive, and challenging, it is imperative for companies to innovate to stay ahead. Scientific advancements and the latest drug technologies are an important response, but artificial intelligence is poised to revolutionize the decision making at the heart of R&D (in)efficiency. Norstella and its constituent brands – Citeline, Evaluate, MMIT, […]

Continue reading on website
Other news

Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

July 8, 2024
The whitepaper, a collaboration between the Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), summarizes a Scientific Exchange held on November 1, 2023.  This event brought together CGT developers, FDA staff, and industry stakeholders to discuss development and regulatory challenges in the CGT field and identify reusabl

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

July 8, 2024
The investment will enable HarmonyCares to bring its in-home value-based primary care model, which already supports 70,000 patients in 15 states, to more people across the U.S.NASHVILLE, Tenn. -- HarmonyCares, a leading provider of value-based in-home longitudinal care, today announced that it has raised $200M of capital to bring its integrated, physician-led in-home care model to more vulnerable